Oral medication for high lp(a) and heart risk
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests an oral medication called HRS-5346 to see if it can lower a type of fat in the blood called lipoprotein(a), which is linked to heart disease. If you have high Lp(a) and are at risk for heart problems, this trial may help reduce that risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a high lipoprotein(a) (Lp(a)) level, which is a type of fat in your blood that can increase heart risk.
- Your doctor says you have a high chance of having a heart attack or stroke.
- You are willing to take the study pill and follow the study schedule.
- You have not had a major heart event (like a heart attack or stroke) in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares how well different forms of an experimental drug are absorbed by the body. Healthy volunteers will receive the drug and have blood tests to see which version works best.
This study tests an experimental oral medication, SAL0137, to see if it can lower Lp(a) levels, a type of fat in the blood linked to heart disease. It may help people who have high Lp(a) and are at increased risk for heart attacks or strokes.
This study tests an investigational medicine given by injection to lower Lp(a), a type of fat linked to heart disease. It may help people with high Lp(a) who already have heart problems or are at increased risk.
This trial tests a new medicine called SRSD216 for people with high levels of lipoprotein (a), a type of fat in the blood that can increase heart disease risk. The study aims to see if the drug is safe and effective at lowering these levels.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
This trial tests two experimental drugs designed to lower lipoprotein(a)—a type of cholesterol particle linked to heart disease—in people whose levels remain high despite taking statins (cholesterol-lowering medications). The goal is to see if these drugs can safely reduce this risk factor.
Hear when a new Lipoprotein Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.